Consider this illustrative ED scenario: an adult receiving cancer care who also takes a thiazide arrives after a generalized seizure with profound hypotonic hyponatremia. After seizure support and protocolized 3% saline, the convulsions stop. Then urine output becomes brisk and dilute, and sodium climbs faster than the infusion alone would predict. The urgent question is whether a new water diuresis—not more saline—is driving the correction.
That change matters because correction can accelerate after hypertonic saline is paused. The ED task is to recognize the shift early, track the rise from the pretreatment sodium, and respond before the correction trajectory becomes unsafe.
Control the symptoms; don’t chase a normal sodium
For an active seizure, support the airway and breathing, check glucose, and treat the convulsion while giving 3% saline under the local severe-hyponatremia pathway. An initial sodium rise of about 4–6 mEq/L is often enough to improve severe neurologic symptoms; many pathways use roughly 5 mmol/L as the early target. That is a partial rescue goal—not a reason to normalize sodium.
Once symptoms improve and the early target is reached, stop repeated hypertonic-saline boluses and reassess. If stupor or seizures persist, continue close monitoring and investigate other causes of altered mental status rather than assuming that more sodium correction is always the answer.
Why sodium can rise after saline is stopped
The sodium concentration reflects both body sodium and body water. When the kidneys suddenly excrete large amounts of dilute urine, the body loses water faster than sodium and the serum sodium can rise quickly—even without additional hypertonic saline.
That shift can follow a change in the underlying physiology. For example, if a reversible stimulus for water retention eases—such as nausea, pain, or hypovolemia, when present—the kidneys may start clearing free water. Stopping a thiazide can also restore the kidney’s ability to dilute urine. Isotonic fluids and potassium replacement can contribute to the overall correction trajectory, so include them in the plan.
A malignancy such as small-cell lung cancer makes SIADH plausible, but it does not prove it. Thiazide exposure complicates interpretation of urine sodium and osmolality, and more than one factor can contribute. Treat the neurologic emergency first; refine the cause after stabilization.
Follow the trajectory, not one lab value
| Change | Why it matters | Practical response |
|---|---|---|
| Seizure stops and sodium rises about 4–6 mEq/L | The immediate symptom-relief goal may be reached | Stop repeated hypertonic saline and reassess; don’t chase a normal value |
| Urine output suddenly increases and urine becomes dilute | A water diuresis may be driving sodium upward | Track output closely and increase the frequency of sodium checks |
| Sodium keeps rising toward the patient’s correction limit | The total change—not just the latest interval—determines the risk | Compare with the pretreatment value and review all fluids and potassium given |
During active correction, check sodium frequently according to the local pathway—often every 2–4 hours when the trajectory is changing. Track urine output as well. European guidance flags a sudden increase above about 100 mL/hour as a warning to check sodium every 2 hours until the rise stabilizes; a catheter is not required solely to measure urine output if it can otherwise be tracked reliably.
Separate the early target from the 24-hour ceiling
Guidelines differ somewhat on the upper correction limit for patients without added risk factors. The European guideline recommends no more than 10 mmol/L in the first 24 hours and 8 mmol/L in each subsequent 24-hour period. U.S. expert recommendations generally use a stricter ceiling of 8 mEq/L in any 24 hours for patients at high risk of osmotic demyelination syndrome (ODS). High-risk features include an initial sodium at or below 105 mEq/L, alcohol use disorder, malnutrition, advanced liver disease, and hypokalemia.
These limits are ceilings, not targets. If duration is unknown, especially with very low sodium or ODS risk factors, use the conservative end of the local pathway. ODS risk is not captured by one number alone, and neurologic injury can occur even when correction stays within a stated limit. At the same time, uncertainty about ODS is not a reason to delay initial rescue treatment for a seizure.
The evidence remains imperfect: ODS is uncommon, and observational studies do not always agree about how correction rate relates to outcomes. A 2026 single-center ED cohort found no association in its primary analysis, but rapid correction was associated with confirmed-or-possible ODS in a sensitivity analysis using more reliable 24-hour sodium estimates. The authors concluded that the findings did not justify abandoning recommended limits. For an individual patient with very low sodium or important risk factors, avoiding unnecessary further rise remains the safer course.
If the rise is too fast, act on the mechanism
If the sodium is nearing or has crossed the applicable limit—or is rapidly rising alongside a brisk dilute diuresis—stop hypertonic saline and other nonessential sodium-raising inputs. Do not withhold resuscitation that is necessary for hemodynamic instability; instead, coordinate it with frequent reassessment and specialist support.
Call critical care and nephrology or an experienced hyponatremia clinician early. Desmopressin can reduce ongoing water loss by suppressing the diuresis. D5W can replace electrolyte-free water and, when appropriate, lower sodium back toward a safer trajectory. Whether to relower, and how to do so, depends on the amount and speed of correction, chronicity, and ODS risk; use a monitored, protocolized plan rather than a fixed response for every patient. Evidence has not established that a proactive desmopressin clamp is necessary for everyone.
New dysarthria, difficulty swallowing, weakness, or movement changes after initial neurologic improvement should prompt evaluation for ODS and other neurologic diagnoses. Do not wait for a presumed complication to appear before addressing a sodium rise that is already accelerating.
Practical takeaways
- Treat the seizure promptly with airway support and protocolized 3% saline; the early goal is partial symptom relief, not normalization.
- A sudden rise in dilute urine output can drive sodium upward after hypertonic saline is stopped.
- Track sodium from the pretreatment baseline, follow urine output, and account for all fluids and potassium replacement.
- If correction is approaching or exceeds the applicable limit, stop nonessential sodium-raising inputs and seek expert guidance; DDAVP and D5W may be used in a monitored relowering plan.
